At a glance

ClinicalIndex Comparison Record

Phase 2Completed· 20 enrolled

Drug / intervention

nebulizing with heliox and oxygenother

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02620956

NCT02620956Phase 2Completed

Compare CT.gov

Aerosol Deposition in Asthmatic Obese Women Using Heliox: A Randomized, Crossover, Controlled Clinical Trial Study

Jacqueline de Melo Barcelar·interventional·Posted Dec 3, 2015·Updated Sep 15, 2016

In Brief

A Phase 2 clinical trial evaluating nebulizing with heliox and oxygen for Obese and Asthma. Completed, enrolled 20 participants across 1 site.

Detailed Summary

BACKGROUND: The aim of this study was to assess pulmonary deposition and distribution of radio-aerosol in obese and normal women, using 2-D planar scintigraphy. METHODS: after inhaling an aerosol of technetium labeled diethylenetriamine penteacetic acid (99mTc - DTPA) with an activity of 1 mCi in a total dose volume with normal saline of 2,5 ml using a vibrating mesh inhaler.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsObese, Asthma

CountriesBrazil

Collaborators--

Timeline

Phase 2CompletedFinished

20162017201820192020202120222023202420252026

Enrollment StartNov 2015

Primary CompletionDec 2015

First PostedDec 2015

Study CompletionJan 2016

TodayJul 2026

First PostedDec 3, 2015

Enrollment StartNov 1, 2015

Primary CompletionDec 1, 2015

Study CompletionJan 1, 2016

TodayJul 2, 2026

Enrollment to primary: 1 monthPosted 10.6 years ago

Interventions

nebulizing with heliox and oxygenother

Mesh Nebulizer with heliox and oxygen. In order to determine the sequence of the gas associated with the inhaled a randomization was performed, sequence 1- first oxygen and second heliox (80:20) or sequence 2- first heliox (80:20) and secondy oxygen.